Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid
Citation
I. Sugitani et al., Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid, WORLD J SUR, 25(5), 2001, pp. 617-622
Categorie Soggetti
Surgery
Journal title
WORLD JOURNAL OF SURGERY
SICI code
0364-2313(200105)25:5<617:PFATSF>2.0.ZU;2-R
Abstract
Although anaplastic thyroid carcinoma (ATC) is one of the most aggressive m
alignancies, a few patients survive for a fairly long time after modern int
ensive treatment. We tried to identify prognostic factors of ATC to assist
in deciding on the proper therapeutic strategy in individual patients, Of 4
7 patients with;ITC (1976-1999), 3 patients with "incidental" ATC (largely
differentiated thyroid carcinoma with a small region of ATC) were excluded
because they had a favorable outcome. The 1-year survival rate of the remai
ning 44 patients with clinically distinct ATC was 16%. The presence of acut
e symptoms, large tumor (> 5 cm), distant metastasis, and leukocytosis (whi
te blood cell count greater than or equal to 10,000/mm(3)) proved to be sig
nificant risk factors. Multivariate analysis by the Cox proportional hazard
model showed that these four factors were independent factors for predicti
ng death from ATC, We devised a novel prognostic index (PI) based on the nu
mber of these four unfavorable characteristics the patient possessed. Patie
nts with a PI of less than or equal to1 had a 62% survival rate at 6 months
, whereas no patients with a PI of greater than or equal to3 survived longe
r than 6 months. All patients with a PI of 4 died from their disease within
3 months. Nine patients received multimodal treatment with a combination o
f surgery, external irradiation, and chemotherapy and had a long survival (
mean 333 +/- 68 days; one patient is still alive and tumor-free), with a me
an PI of 0.6, Our PI is useful as a means of selecting patients for aggress
ive therapy. When the PI is low, multimodal treatment should be attempted t
o obtain the best survival results; if it is high most patients are too ser
iously ill to tolerate intensive treatment and palliative therapy is recomm
ended.